位置:首页 > 蛋白库 > H33B_DROME
H33B_DROME
ID   H33B_DROME              Reviewed;         136 AA.
AC   C0HL67; A4V466; E2QCP0; P06351; P33155; P84249; Q9V3W4;
DT   28-FEB-2018, integrated into UniProtKB/Swiss-Prot.
DT   28-FEB-2018, sequence version 1.
DT   03-AUG-2022, entry version 28.
DE   RecName: Full=Histone H3.3B {ECO:0000303|PubMed:7557364};
DE   AltName: Full=H3.B {ECO:0000312|FlyBase:FBgn0004828};
GN   Name=His3.3B {ECO:0000303|PubMed:7557364, ECO:0000312|FlyBase:FBgn0004828};
GN   ORFNames=CG8989 {ECO:0000312|FlyBase:FBgn0004828};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1748304; DOI=10.1016/0378-1119(91)90337-b;
RA   Fretzin S., Allan B.D., van Daal A., Elgin S.C.R.;
RT   "A Drosophila melanogaster H3.3 cDNA encodes a histone variant identical
RT   with the vertebrate H3.3.";
RL   Gene 107:341-342(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Canton-S;
RX   PubMed=7557364; DOI=10.1139/g95-075;
RA   Akhmanova A.S., Bindels P.S.T., Xu J., Miedema K., Kremer H., Hennig W.;
RT   "Structure and expression of histone H3.3 genes in Drosophila melanogaster
RT   and Drosophila hydei.";
RL   Genome 38:586-600(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6] {ECO:0000312|EMBL:ANY27398.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley {ECO:0000312|EMBL:ANY27398.1};
RA   Wan K., Booth B., Spirohn K., Hao T., Hu Y., Calderwood M., Hill D.,
RA   Mohr S., Vidal M., Celniker S., Perrimon N.;
RL   Submitted (JUL-2016) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PHOSPHORYLATION AT SER-11, AND ACETYLATION AT LYS-10 AND LYS-15.
RX   PubMed=11114889; DOI=10.1101/gad.848800;
RA   Nowak S.J., Corces V.G.;
RT   "Phosphorylation of histone H3 correlates with transcriptionally active
RT   loci.";
RL   Genes Dev. 14:3003-3013(2000).
RN   [8]
RP   PHOSPHORYLATION AT SER-11, AND ACETYLATION AT LYS-15.
RX   PubMed=11371341; DOI=10.1016/s0092-8674(01)00325-7;
RA   Wang Y., Zhang W., Jin Y., Johansen J., Johansen K.M.;
RT   "The JIL-1 tandem kinase mediates histone H3 phosphorylation and is
RT   required for maintenance of chromatin structure in Drosophila.";
RL   Cell 105:433-443(2001).
RN   [9]
RP   PHOSPHORYLATION AT SER-11.
RX   PubMed=11266459; DOI=10.1083/jcb.152.4.669;
RA   Giet R., Glover D.M.;
RT   "Drosophila aurora B kinase is required for histone H3 phosphorylation and
RT   condensin recruitment during chromosome condensation and to organize the
RT   central spindle during cytokinesis.";
RL   J. Cell Biol. 152:669-682(2001).
RN   [10]
RP   PHOSPHORYLATION AT SER-11.
RX   PubMed=12514098; DOI=10.1101/gad.1021403;
RA   Labrador M., Corces V.G.;
RT   "Phosphorylation of histone H3 during transcriptional activation depends on
RT   promoter structure.";
RL   Genes Dev. 17:43-48(2003).
RN   [11]
RP   FUNCTION, METHYLATION AT LYS-5; LYS-10; LYS-15; LYS-28; LYS-37; LYS-38 AND
RP   LYS-80, ACETYLATION AT LYS-10; LYS-15; LYS-19 AND LYS-24, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14732680; DOI=10.1073/pnas.0308092100;
RA   McKittrick E., Gafken P.R., Ahmad K., Henikoff S.;
RT   "Histone H3.3 is enriched in covalent modifications associated with active
RT   chromatin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:1525-1530(2004).
RN   [12]
RP   METHYLATION AT LYS-80.
RX   PubMed=15371351; DOI=10.1534/genetics.104.033191;
RA   Shanower G.A., Mueller M., Blanton J.L., Honti V., Gyurkovics H.,
RA   Schedl P.;
RT   "Characterization of the grappa gene, the Drosophila histone H3 lysine 79
RT   methyltransferase.";
RL   Genetics 169:173-184(2005).
RN   [13]
RP   SUCCINYLATION AT LYS-57 AND LYS-80.
RX   PubMed=22389435; DOI=10.1074/mcp.m111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [14]
RP   INTERACTION WITH DAXX.
RX   PubMed=28320872; DOI=10.1128/mcb.00597-16;
RA   Fromental-Ramain C., Ramain P., Hamiche A.;
RT   "The Drosophila DAXX-Like Protein (DLP) Cooperates with ASF1 for H3.3
RT   Deposition and Heterochromatin Formation.";
RL   Mol. Cell. Biol. 37:0-0(2017).
CC   -!- FUNCTION: Variant histone H3 which replaces conventional H3 in a wide
CC       range of nucleosomes in active genes and is specifically enriched in
CC       modifications associated with active chromatin. Constitutes the
CC       predominant form of histone H3 in non-dividing cells and is
CC       incorporated into chromatin independently of DNA synthesis. Deposited
CC       at sites of nucleosomal displacement throughout transcribed genes,
CC       suggesting that it represents an epigenetic imprint of
CC       transcriptionally active chromatin. Nucleosomes wrap and compact DNA
CC       into chromatin, limiting DNA accessibility to the cellular machineries
CC       which require DNA as a template. Histones thereby play a central role
CC       in transcription regulation, DNA repair, DNA replication and
CC       chromosomal stability. DNA accessibility is regulated via a complex set
CC       of post-translational modifications of histones, also called histone
CC       code, and nucleosome remodeling. {ECO:0000269|PubMed:14732680}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. Interacts with Daxx (via C-terminus) (PubMed:28320872).
CC       {ECO:0000269|PubMed:28320872}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Low levels of expression in ovaries and moderate
CC       levels of expression in the testes. Highest levels of expression in
CC       embryos. {ECO:0000269|PubMed:7557364}.
CC   -!- PTM: Phosphorylation at Ser-11 by aurB/ial during mitosis and meiosis
CC       is crucial for chromosome condensation and cell-cycle progression.
CC       Phosphorylation at Ser-11 by JIL-1 during interphase is linked to gene
CC       activation and restricts the formation of heterochromatin at
CC       inappropriate sites. Phosphorylation at Ser-11 is enriched on male X
CC       chromosome compared to the autosome. {ECO:0000269|PubMed:11114889,
CC       ECO:0000269|PubMed:11266459, ECO:0000269|PubMed:11371341,
CC       ECO:0000269|PubMed:12514098}.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylated on
CC       Lys-15 during prophase I of meiosis. Phosphorylation of H2A 'Thr-119'
CC       is a prerequisite for H3 Lys-15 acetylation. Acetylation on Lys-15 is
CC       enriched on male X chromosome compared to the autosome.
CC       {ECO:0000269|PubMed:11114889, ECO:0000269|PubMed:11371341,
CC       ECO:0000269|PubMed:14732680}.
CC   -!- PTM: Methylation at Lys-5 or Lys-80 is generally associated with active
CC       chromatin. Methylation at Lys-80 by gpp occurs at low levels in
CC       specific developmental stages and tissues undergoing active cell
CC       division, and at highest levels in epidermal cells undergoing
CC       differentiation. {ECO:0000269|PubMed:14732680,
CC       ECO:0000269|PubMed:15371351}.
CC   -!- MISCELLANEOUS: This histone is the predominant form in non-dividing
CC       cells.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X53822; CAA37819.1; -; mRNA.
DR   EMBL; X81205; CAA57077.1; -; Genomic_DNA.
DR   EMBL; X81207; CAA57080.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAF46452.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAN09245.1; -; Genomic_DNA.
DR   EMBL; AE014298; AAO41645.1; -; Genomic_DNA.
DR   EMBL; AE014298; AGB95217.1; -; Genomic_DNA.
DR   EMBL; AY118325; AAM48354.1; -; mRNA.
DR   EMBL; KX531588; ANY27398.1; -; mRNA.
DR   PIR; S61220; S61220.
DR   RefSeq; NP_001259374.1; NM_001272445.2.
DR   RefSeq; NP_001260082.1; NM_001273153.1.
DR   RefSeq; NP_511095.1; NM_078540.5.
DR   RefSeq; NP_523479.1; NM_078755.3.
DR   RefSeq; NP_723056.2; NM_164624.3.
DR   RefSeq; NP_727314.1; NM_167180.4.
DR   RefSeq; NP_788892.1; NM_176719.1.
DR   AlphaFoldDB; C0HL67; -.
DR   SMR; C0HL67; -.
DR   iPTMnet; C0HL67; -.
DR   DNASU; 33736; -.
DR   EnsemblMetazoa; FBtr0071345; FBpp0071280; FBgn0004828.
DR   EnsemblMetazoa; FBtr0071346; FBpp0071281; FBgn0004828.
DR   EnsemblMetazoa; FBtr0071347; FBpp0071282; FBgn0004828.
DR   EnsemblMetazoa; FBtr0079010; FBpp0078649; FBgn0014857.
DR   EnsemblMetazoa; FBtr0333536; FBpp0305716; FBgn0014857.
DR   EnsemblMetazoa; FBtr0333537; FBpp0305717; FBgn0014857.
DR   EnsemblMetazoa; FBtr0340343; FBpp0309302; FBgn0004828.
DR   GeneID; 31848; -.
DR   GeneID; 33736; -.
DR   KEGG; dme:Dmel_CG5825; -.
DR   KEGG; dme:Dmel_CG8989; -.
DR   CTD; 31848; -.
DR   CTD; 33736; -.
DR   FlyBase; FBgn0004828; His3.3B.
DR   VEuPathDB; VectorBase:FBgn0004828; -.
DR   VEuPathDB; VectorBase:FBgn0014857; -.
DR   OMA; SDCERRK; -.
DR   Reactome; R-DME-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-DME-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-DME-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-DME-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-DME-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-DME-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-DME-68616; Assembly of the ORC complex at the origin of replication.
DR   Reactome; R-DME-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-DME-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-DME-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-DME-983231; Factors involved in megakaryocyte development and platelet production.
DR   PRO; PR:C0HL67; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0004828; Expressed in brain and 27 other tissues.
DR   ExpressionAtlas; C0HL67; baseline and differential.
DR   Genevisible; P84249; DM.
DR   GO; GO:0000786; C:nucleosome; IDA:FlyBase.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005700; C:polytene chromosome; IDA:FlyBase.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0030527; F:structural constituent of chromatin; IGI:FlyBase.
DR   GO; GO:0006334; P:nucleosome assembly; NAS:UniProtKB.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; DNA-binding; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250"
FT   CHAIN           2..136
FT                   /note="Histone H3.3B"
FT                   /id="PRO_0000443324"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11114889,
FT                   ECO:0000269|PubMed:14732680"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         15
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:11114889,
FT                   ECO:0000269|PubMed:11371341, ECO:0000269|PubMed:14732680"
FT   MOD_RES         15
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         37
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         37
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         38
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         38
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680"
FT   MOD_RES         57
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000269|PubMed:22389435"
FT   MOD_RES         80
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680,
FT                   ECO:0000269|PubMed:15371351"
FT   MOD_RES         80
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:14732680,
FT                   ECO:0000269|PubMed:15371351"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:22389435"
SQ   SEQUENCE   136 AA;  15328 MW;  5158ED279E6F9E1C CRC64;
     MARTKQTARK STGGKAPRKQ LATKAARKSA PSTGGVKKPH RYRPGTVALR EIRRYQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSAAI GALQEASEAY LVGLFEDTNL CAIHAKRVTI
     MPKDIQLARR IRGERA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024